华东医药三类医疗器械MaiLi Precise注册申请获得受理

Core Viewpoint - Huadong Medicine's subsidiary, Xinkelimeixue (Hangzhou) Medical Technology Co., Ltd., has received a Notice of Acceptance from the National Medical Products Administration (NMPA) for its Class III medical device registration application for MaiLi Precise, a cross-linked hyaluronic acid gel containing lidocaine [1] Group 1 - The MaiLi series consists of four high-end hyaluronic acid gel products: MaiLi Precise, MaiLi Define, MaiLi Volume, and MaiLi Extreme, all of which are already marketed in Europe [1] - The registration application for MaiLi Precise has been officially accepted, indicating progress in the regulatory approval process in China [1]